T6277

Doramapimod (BIRB 796) is a highly potent inhibitor of p38 MAPK (Kd: 0.1 nM), but weakly inhibits c-RAF, Fyn, Lck, ERK-1, SYK, IKK2, and ZAP-70.

DAD is an ion channel blocker (blocks voltage-gated potassium channels) and is a third generation photoelectric switch that responds to visible light.

AKT-IN-9, a potent inhibitor of AKT, holds potential for breast and prostate cancer research.

TPB15 is an orally active inhibitor of Hh (Hedgehog) signalling. TPB15 significantly blocks the MDA-MB-468 cell cycle and induces apoptosis. TPB15 blocks Smo (Smoothened) translocation into cilia and reduces Smo protein and mRNA expression. TPB15 has good anti-tumour effects and low toxicity.

OX11 is a selective inhibitor of S. pneumoniae, P. aeruginosa, and E. coli bacteria.

BS-181 dihydrochloride is a selective and potent inhibitor of CDK7 with an IC50 value of 21 nM. BS-181 dihydrochloride inhibits CDK2 (IC50: 880 nM), CDK5 (IC50: 3000 nM) and CDK9 (IC50: 4200 nM), but does not block CDK1, 4 and 6. BS-181 dihydrochloride inhibits the growth of a group of cancer cells (IC50: 11.5 μM-37.3 μM) and induces apoptosis.

CCT245232 is a potent inhibitor of heat-stimulated factor 1 (HSF1) with potential applications in studies of proliferative diseases, such as cancer.

EGFR/HER2-IN-2 (Compound ZINC35560729) is a dual inhibitor targeting EGFR (IC50: 5.02 μM) and HER2 (IC50: 0.83 μM).

EGFR/HER2-IN-3 (Compound ZINC21942954) is a dual inhibitor of EGFR and HER2.

Axl-IN-9 is a potent inhibitor of AXL (IC50: 26 nM) with excellent transmembrane properties.Axl-IN-9 exhibits good pharmacokinetic properties in animals.Axl-IN-9 can be used to study proliferative, autoimmune, allergic, transplant rejection, inflammatory, cancer or other mammalian diseases.

PI3K-IN-35 (Compound 6l) is a highly selective inhibitor of PI3K, targeting PI3K-α (IC50: 13.98 μM), PI3K-β (IC50: 7.22 μM), and PI3K-δ (IC50: 10.94 μM). It blocks the cell cycle in the G2/M phase and induces apoptosis, making it useful for studying leukemia.